3dds: Difference between revisions
No edit summary |
No edit summary |
||
| Line 23: | Line 23: | ||
==About this Structure== | ==About this Structure== | ||
3DDS is a | 3DDS is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3DDS OCA]. | ||
==Reference== | ==Reference== | ||
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy., Thomson SA, Banker P, Bickett DM, Boucheron JA, Carter HL, Clancy DC, Cooper JP, Dickerson SH, Garrido DM, Nolte RT, Peat AJ, Sheckler LR, Sparks SM, Tavares FX, Wang L, Wang TY, Weiel JE, Bioorg Med Chem Lett. 2008 Dec 25. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/19138846 19138846] | |||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Phosphorylase]] | [[Category: Phosphorylase]] | ||
[[Category: | [[Category: Single protein]] | ||
[[Category: Pdbx_ordinal=, <PDBx:audit_author.]] | |||
[[Category: Acetylation]] | [[Category: Acetylation]] | ||
[[Category: Allosteric enzyme]] | [[Category: Allosteric enzyme]] | ||
| Line 46: | Line 47: | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Mar 4 20:12:24 2009'' | ||
Revision as of 21:12, 4 March 2009
Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK261
Template:ABSTRACT PUBMED 19138846
DiseaseDisease
Known disease associated with this structure: Glycogen storage disease VI OMIM:[232700]
About this StructureAbout this Structure
3DDS is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy., Thomson SA, Banker P, Bickett DM, Boucheron JA, Carter HL, Clancy DC, Cooper JP, Dickerson SH, Garrido DM, Nolte RT, Peat AJ, Sheckler LR, Sparks SM, Tavares FX, Wang L, Wang TY, Weiel JE, Bioorg Med Chem Lett. 2008 Dec 25. PMID:19138846 [[Category: Pdbx_ordinal=, <PDBx:audit_author.]]
Page seeded by OCA on Wed Mar 4 20:12:24 2009
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCA- Pages with broken file links
- Homo sapiens
- Phosphorylase
- Single protein
- Acetylation
- Allosteric enzyme
- Carbohydrate metabolism
- Diabetes
- Disease mutation
- Glycogen metabolism
- Glycogen phosphorylase
- Glycogen storage disease
- Glycosyltransferase
- Gp
- Nucleotide-binding
- Phosphoprotein
- Polymorphism
- Pyridoxal phosphate
- Transferase